World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website https://www.wjon.org

Review

Volume 14, Number 5, October 2023, pages 340-349


Biology of Mesothelin and Clinical Implications: A Review of Existing Literature

Table

Table 1. Summary of Mesothelin Positivity in Selected Tumor Types Across Multiple Reports and Antibodies Used
 
Tumor typeReference# PositivemAb usedTotal portion positive
*Non-mucinous. Totals do not include those stained with 5B2 by Inaguma et al to avoid counting the same patients twice.
Epithelioid mesotheliomaChang [19]15/15K1150/163 (92.0%)
Ordonez [20]44/445B2
Weidemann [24]16/25MSVA-235
Inaguma [33]73/795B2
Inaguma [33]75/79MN1
Epithelial ovarian cancer*Chang [19]10/15K1617/655 (94.2%)
Hassan [25]34/48K1
Ordonez [20]32/345B2
Weidemann [24]497/511MSVA-235
Inaguma [33]42/475B2
Inaguma [33]44/47MN1
Pancreatic adenocarcinomaOrdonez [20]12/145B2267/298 (89.6%)
Hassan [21]18/185B2
Argani [22]60/605B2
Johnston [26]10/105B2
Weidemann [24]48/64MSVA-235
Inaguma [33]100/1325B2
Inaguma [33]119/132MN1
Gastric adenocarcinomaOrdonez [20]2/75B2920/1,878 (49.0%)
Baba [27]124/212HBME-1
Einama [28]49/1105B2
Han [29]30/117Not reported
Shin [30]476/958SP74
Weidemann [24]176/393MSVA-235
Inaguma [33]60/815B2
Inaguma [33]63/81MN1
Triple negative breast cancerTchou [23]29/435B2178/449 (39.6%)
Bayoglu [31]30/71SP74
Tozbikian [32]82/2265B2
Parinyanitikul [34]37/1095B2